- Home
- LPSN vs DYAI Comparison
LPSN vs DYAI Comparison
Compare LPSN & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPSN
- DYAI
- Stock Information
- Founded
- LPSN 1995
- DYAI 1979
- Country
- LPSN United States
- DYAI United States
- Employees
- LPSN N/A
- DYAI N/A
- Industry
- LPSN EDP Services
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LPSN Technology
- DYAI Health Care
- Exchange
- LPSN Nasdaq
- DYAI Nasdaq
- Market Cap
- LPSN 93.0M
- DYAI N/A
- IPO Year
- LPSN 2000
- DYAI 2004
- Fundamental
- Price
- LPSN $1.18
- DYAI $1.13
- Analyst Decision
- LPSN Hold
- DYAI Strong Buy
- Analyst Count
- LPSN 6
- DYAI 1
- Target Price
- LPSN $1.18
- DYAI $6.00
- AVG Volume (30 Days)
- LPSN 1.9M
- DYAI 33.8K
- Earning Date
- LPSN 11-06-2024
- DYAI 11-06-2024
- Dividend Yield
- LPSN N/A
- DYAI N/A
- EPS Growth
- LPSN N/A
- DYAI N/A
- EPS
- LPSN N/A
- DYAI N/A
- Revenue
- LPSN $361,824,000.00
- DYAI $1,804,108.00
- Revenue This Year
- LPSN N/A
- DYAI $19.64
- Revenue Next Year
- LPSN N/A
- DYAI $126.47
- P/E Ratio
- LPSN N/A
- DYAI N/A
- Revenue Growth
- LPSN N/A
- DYAI N/A
- 52 Week Low
- LPSN $0.45
- DYAI $0.93
- 52 Week High
- LPSN $3.98
- DYAI $2.67
- Technical
- Relative Strength Index (RSI)
- LPSN 52.19
- DYAI 48.53
- Support Level
- LPSN $1.09
- DYAI $1.01
- Resistance Level
- LPSN $1.19
- DYAI $1.24
- Average True Range (ATR)
- LPSN 0.08
- DYAI 0.09
- MACD
- LPSN 0.00
- DYAI 0.02
- Stochastic Oscillator
- LPSN 48.00
- DYAI 64.52
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation.. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.